Phosphodiesterase 4 inhibition attenuates atrial natriuretic peptide-induced vascular hyperpermeability and loss of plasma volume.
about
Tonic regulation of vascular permeabilityUltrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.Endothelial actions of atrial and B-type natriuretic peptidesErythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels.AqF026 is a pharmacologic agonist of the water channel aquaporin-1.Rolipram improves renal perfusion and function during sepsis in the mouse.The role of atrial natriuretic peptide to attenuate inflammation in a mouse skin wound and individually perfused rat mesenteric microvessels.Increased microvascular permeability in mice lacking Epac1 (Rapgef3).Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect.Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis.Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.Quantification of osmotic water transport in vivo using fluorescent albumin.Phosphodiesterase 4 inhibition attenuates plasma volume loss and transvascular exchange in volume-expanded mice.Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System.
P2860
Q26863424-D313AA7C-DA2B-4BB8-9508-678515193C8DQ30514138-84800DAD-DFFE-4C3A-8BEF-4C9FC775C833Q36159149-00D8FA11-83B4-4292-8872-1F8ECF2C6810Q36312740-94F3707F-34D2-483F-807A-C814CEFB7F22Q36977371-880140A4-2CCE-4AAB-B894-BF047D04EF15Q37252021-B38B38C7-584A-4DBD-AC17-09177EE39C9DQ37286819-9E2AADDF-9F16-4314-8CFB-9A1F600FBB50Q37354927-6242272F-A402-4868-A55F-D4D303C8BC2FQ37656088-6BC4487B-6546-4218-824D-EC3176366739Q41230754-1B1A8D95-E2ED-42F1-B257-0CED169B3A23Q45368304-BC86A424-F2C8-45AA-9421-56C9DB226E89Q45739464-5CEA3A31-5632-4F9F-AF86-1525DD520724Q46981885-4172B9B8-D0D5-4E43-8BA3-BAA28A976750Q52809588-528D0BD9-F706-4CE2-A6A9-42076021D4CC
P2860
Phosphodiesterase 4 inhibition attenuates atrial natriuretic peptide-induced vascular hyperpermeability and loss of plasma volume.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@en
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@nl
type
label
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@en
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@nl
prefLabel
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@en
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@nl
P2093
P2860
P1476
Phosphodiesterase 4 inhibition ...... ity and loss of plasma volume.
@en
P2093
Eugene M Renkin
Fitz-Roy E Curry
Haris Samardzic
Joyce F Clark
Roger H Adamson
Yueh-Chen Lin
P2860
P304
P356
10.1113/JPHYSIOL.2010.199588
P407
P50
P577
2010-11-22T00:00:00Z